A review of the clinical and genetic aspects of aniridia

Seminars in Ophthalmology

Volumn 28, Issue 5-6, 2013, Pages 306-312

  Lee, Hyunjoo J ^a   Colby, Kathryn A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Aniridia; Genetics; Keratopathy; Keratoprosthesis; PAX6

Indexed keywords

TRANSCRIPTION FACTOR PAX6;

ALLOGRAFT; ANIRIDIA; ANIRIDIA ASSOCIATED KERATOPATHY; AUTOSOMAL DOMINANT INHERITANCE; CLINICAL FEATURE; CORNEA LIMBUS; DNA MODIFICATION; GENE DELETION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GLAUCOMA; HAPLOINSUFFICIENCY; HEREDITY; HUMAN; KERATITIS; KERATOPATHY; KERATOPLASTY; KERATOPROSTHESIS; LOSS OF FUNCTION MUTATION; MOLECULAR GENETICS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION;

ANIRIDIA; CORNEAL DISEASES; EYE PROTEINS; GENE DELETION; HOMEODOMAIN PROTEINS; HUMANS; MUTATION; PAIRED BOX TRANSCRIPTION FACTORS; REPRESSOR PROTEINS;

EID: 84886395115     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.3109/08820538.2013.825293     Document Type: Review

References (37)

1. Nelson LB, Spaeth GL, Nowinski TS, et al. Aniridia: A review. Surv Ophthalmol 1984;28(6):621-642.
2. Eden U, Iggman D, Riise R, Tornqvist K. Epidemiology of aniridia in Sweden and Norway. Acta Ophthalmol 2008; 86(7):727-729.
3. Hu DN. Prevalence and mode of inheritance of major genetic eye diseases in China. Am J Med Genet 1987; 24(10):584-588.
4. Eden U, Riise R, Tornqvist K. Corneal involvement in congenital aniridia. Cornea 2010;29(10):1096-1102.
5. Netland PA, Scott ML, Boyle JWt, Lauderdale JD. Ocular and systemic findings in a survey of aniridia subjects. Journal of AAPOS: The Official Publication of the American Association for Pediatric Ophthalmology and Strabismus/American Association for Pediatric Ophthalmology and Strabismus 2011;15(6):562-566.
6. Hingorani M, Williamson KA, Moore AT, van Heyningen V. Detailed ophthalmologic evaluation of 43 individuals with PAX6 mutations. Invest Ophthalmol Vis Sci 2009; 50(6):2581-2590.
7. Mayer KL, Nordlund ML, Schwartz GS, Holland EJ. Keratopathy in congenital aniridia. Ocul Surf 2003; 1(2):74-79.
8. Skeens HM, Brooks BP, Holland EJ. Congenital aniridia variant: Minimally abnormal irides with severe limbal stem cell deficiency. Ophthalmology 2011;118(7):1260-1264.
9. Mirzayans F, Pearce WG, MacDonald IM, Walter MA. Mutation of the PAX6 gene in patients with autosomal dominant keratitis. Am J Hum Genet 1995;57(3):539-548.
10. Pearce WG, Mielke BW, Hassard DT, et al. Autosomal dominant keratitis: a possible aniridia variant. Canadian Journal of Ophthalmology/Journal Canadien d'Ophtalmologie 1995;30(3):131-137.
11. Breslow NE, Norris R, Norkool PA, et al. Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: A report from the National Wilms Tumor Study Group. J Clin Oncol: Official Journal of the American Society of Clinical Oncology 2003;21(24):4579-4585.
12. Boughamoura L, Yacoub M, Abroug M, et al. [Gillespie syndrome: 2 familial cases]. Arch Pediatr 2006; 13(10):1323-1325.
13. Nevin NC, Lim JH. Syndrome of partial aniridia, cerebellar ataxia, and mental retardation: Gillespie syndrome. Am J Med Genet 1990;35(4):468-469.
14. Axton R, Hanson I, Danes S, et al. The incidence of PAX6 mutation in patients with simple aniridia: An evaluation of mutation detection in 12 cases. J Med Genet 1997; 34(4):279-286.
15. Kokotas H, Petersen MB. Clinical and molecular aspects of aniridia. Clin Genet 2010;77(5):409-420.
16. Jordan T, Hanson I, Zaletayev D, et al. The human PAX6 gene is mutated in two patients with aniridia. Nat Genet 1992;1(5):328-332.
17. Ton CC, Hirvonen H, Miwa H, et al. Positional cloning and characterization of a paired box-and homeobox-containing gene from the aniridia region. Cell 1991;67(6):1059-1074.
18. Ton CC, Miwa H, Saunders GF. Small eye (Sey): Cloning and characterization of the murine homolog of the human aniridia gene. Genomics 1992;13(2):251-256.
19. Churchill A, Booth A. Genetics of aniridia and anterior segment dysgenesis. Br J Ophthalmol 1996;80(7):669-673.
20. Halder G, Callaerts P, Gehring WJ. Induction of ectopic eyes by targeted expression of the eyeless gene in Drosophila. Science 1995;267(5205):1788-1792.
21. Lim HT, Seo EJ, Kim GH, et al. Comparison between aniridia with and without PAX6 mutations: Clinical and molecular analysis in 14 Korean patients with aniridia. Ophthalmology 2012;119(6):1258-1264.
22. Wawrocka A, Budny B, Debicki S, et al. PAX6 3' deletion in a family with aniridia. Ophthalmic Genet 2012;33(1):44-48.
23. Brown A, McKie M, van Heyningen V, Prosser J. The Human PAX6 Mutation Database. Nucleic Acids Res 1998; 26(1):259-264.
24. Khajavi M, Inoue K, Lupski JR. Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur J Hum Genet 2006;14(10):1074-1081.
25. Tzoulaki I, White IM, Hanson IM. PAX6 mutations: Genotype-phenotype correlations. BMC Genet 2005;6:27.
26. Hanson IM, Fletcher JM, Jordan T, et al. Mutations at the PAX6 locus are found in heterogeneous anterior segment malformations including Peters' anomaly. Nat Genet 1994; 6(2):168-173.
27. Robinson DO, Howarth RJ, Williamson KA, et al. Genetic analysis of chromosome 11p13 and the PAX6 gene in a series of 125 cases referred with aniridia. Am J Med Genet A 2008;146A(5):558-569.
28. Ito YA, Footz TK, Berry FB, et al. Severe molecular defects of a novel FOXC1 W152G mutation result in aniridia. Invest Ophthalmol Vis Sci 2009;50(8):3573-3579.
29. Kloss BA, Reis LM, Bremond-Gignac D, et al. Analysis of FOXD3 sequence variation in human ocular disease. Molecular Vision 2012;18:1740-1749.
30. Glaser T, Ton CC, Mueller R, et al. Absence of PAX6 gene mutations in Gillespie syndrome (partial aniridia, cerebel-lar ataxia, and mental retardation). Genomics 1994; 19(1):145-148.
31. Ramaesh K, Ramaesh T, Dutton GN, Dhillon B. Evolving concepts on the pathogenic mechanisms of aniridia related keratopathy. Int J Biochem Cell Biol 2005;37(3):547-557.
32. Bakhtiari P, Chan C, Welder JD, et al. Surgical and visual outcomes of the type I Boston Keratoprosthesis for the management of aniridic fibrosis syndrome in congenital aniridia. Am J Ophthalmol 2012;153(5):967-971.
33. Gomes JA, Eagle Jr RC, Gomes AK, et al. Recurrent keratopathy after penetrating keratoplasty for aniridia. Cornea 1996;15(5):457-462.
34. Kremer I, Rajpal RK, Rapuano CJ, et al. Results of penetrating keratoplasty in aniridia. Am J Ophthalmol 1993;115(3):317-320.
35. Holland EJ, Djalilian AR, Schwartz GS. Management of aniridic keratopathy with keratolimbal allograft: a limbal stem cell transplantation technique. Ophthalmology 2003; 110(1):125-130.
36. Akpek EK, Harissi-Dagher M, Petrarca R, et al. Outcomes of Boston keratoprosthesis in aniridia: A retrospective multicenter study. Am J Ophthalmol 2007;144(2):227-231.
37. Rixen JJ, Cohen AW, Kitzmann AS, et al. Treatment of aniridia With Boston type I keratoprosthesis. Cornea 2013;32(7):947-950.